Atlas Trials

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research

Clinical trial NCT05747157 · UNKNOWN

Trial details

NCT number
NCT05747157
Sponsor
Anhui Provincial Hospital
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
B-cell Acute Lymphoblastic Leukemia
Start date
2023-02-15
Primary completion
2025-02-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.